|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | A61K 38/48 | (2006.01) |
| A61P 7/04 | (2006.01) |
| (11) | Number of the document | 1343523 |
| (13) | Kind of document | T |
| (96) | European patent application number | 01995705.9 |
| Date of filing the European patent application | 2001-12-20 | |
| (97) | Date of publication of the European application | 2003-09-17 |
| (45) | Date of publication and mention of the grant of the patent | 2007-02-14 |
| (46) | Date of publication of the claims translation | 2007-05-25 |
| (86) | Number | PCT/EP2001/015132 |
| Date | 2001-12-20 |
| (87) | Number | WO 2002/049665 |
| Date | 2002-06-27 |
| (30) | Number | Date | Country code |
| 00128252 | 2000-12-21 | EP |
| (72) |
SKAMIRA, Cord, DE
STASSEN, Jean, Marie, BE
HEUSEL, Gerhard, DE
WIENEN, Wolfgang, DE
|
| (73) |
Boehringer Ingelheim Pharma GmbH & Co. KG,
55216 Ingelheim am Rhein,
DE
|
| (74) |
Leonas Antanas KUČINSKAS,
Dr. Leono A. Kučinsko patentinių paslaugų firma, Kaštonų g. 5-7, LT-01107 Vilnius,
LT
|
| (54) | Aktyvuoto krešėjimo faktoriaus VII panaudojimas trombolitinės terapijos indikuotų gausių kraujavimų gydymui |
| USE OF ACTIVATED COAGULATION FACTOR VII FOR TREATING THROMBOLYTIC THERAPY-INDUCED MAJOR BLEEDINGS |
| Payment date | Validity (years) | Amount | |
| 2009-11-24 | 9 | 720.00 LTL |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2010-12-20 |